Updated:
EMV Capital
EMV Capital manages 70-plus early-stage deep tech and life sciences companies through a public balance sheet, third-party funds, and syndicated...
EMV Capital
EMV Capital structures its venture operation through a hybrid of direct PLC balance sheet investments, fund management mandates, and syndicated co-investments across a portfolio that has grown to more than 70 companies. The firm targets early-stage businesses with defensible intellectual property in deep tech and life sciences, concentrating on specific cohorts to provide fundraising support, IP strategy, executive placement, and exit-readiness services through an in-house team. Confirmed portfolio positions include Cambridge GaN Devices, Paragraf, NU Quantum, FocalPoint Positioning, and Infinitopes, while sector coverage spans industrials, robotics, artificial intelligence, quantum, space systems, and healthcare. Geographic deployment concentrates on the United Kingdom, with select US-linked companies and an office in Cambridge alongside its London headquarters. EMV Capital is quoted on the AIM market of the London Stock Exchange and generates operational income through fee-based management services alongside capital gains from direct disposals and carried interest from fund exits. The firm manages the Evergreen EIS and Martlet Capital Funds, which provide committed third-party capital alongside its own balance sheet, while its syndication network draws in co-investors for specific deals. In May 2026, the firm published an investor presentation covering the twelve months to December 2025, confirming 70-plus companies under management and a dual focus on direct cash realizations and fund carry. The practical differentiator is the capital-efficient operating model: EMV does not rely on a single closed-end fund structure but instead layers a public permanent-capital vehicle, multiple third-party managed funds, and deal-by-deal syndicates. The firm takes board seats, works closely with management teams, and deploys venture partners and an expert service-provider panel to accelerate value creation, then exits positions through M&A, IPOs, or sales to private equity and financial buyers. This architecture gives EMV the flexibility to invest from seed through late stage without the fixed deployment schedules that define traditional venture partnerships.
General information
Firm type
Private Equity
Year founded
—
AUM
Undisclosed
Location
Region
Europe
Country
United Kingdom
City
London
Corporate office
2nd Floor, 25-28 Old Burlington Street, London W1S 3AN, United Kingdom
Additional offices
Cambridge
Sector focus
Frequently asked questions
How is EMV Capital structured — is it a traditional venture fund or something else?
EMV Capital functions as a publicly quoted venture capital investment group on the AIM market of the London Stock Exchange, rather than operating as a single closed-end fund. It deploys capital through three channels: direct investment from its own PLC balance sheet, management of third-party funds including the Evergreen EIS and Martlet Capital Funds, and syndicated deals that bring in co-investors. This layered structure allows EMV to back companies from early stage through to exit without the fixed capital deployment and return deadlines that define traditional venture partnerships, while generating returns through both direct equity stakes and carried interest on fund exits.
Which sectors and stages does EMV Capital target?
EMV targets early-stage companies in deep tech and life sciences that hold attractive intellectual property, with deployment spanning sectors such as artificial intelligence, quantum computing, robotics, space systems, and healthcare. The firm focuses on companies from seed through late stage, with a portfolio that includes positions in Cambridge GaN Devices, Paragraf, NU Quantum, FocalPoint Positioning, and Infinitopes. Its operating model emphasizes proactive management and value creation services aimed at advancing portfolio companies to critical inflection points, with exits achieved through M&A, IPOs, or sales to private equity and financial investors.
Does EMV Capital invest directly or through funds?
EMV invests both directly and through managed funds. The firm uses its own balance sheet to take direct equity stakes in portfolio companies, while also serving as the manager of the Evergreen EIS and Martlet Capital Funds, which pool third-party investor capital. In addition, EMV assembles syndicated co-investments from its network of external investors for specific opportunities. This combination gives the firm multiple pathways to increase ownership in companies and earn returns through capital gains on direct positions and carried interest on fund realizations.
Where does EMV Capital’s operational income come from?
EMV generates operational income through a combination of fee-based management services and modest divestments from its portfolio holdings. The firm charges fees for the proactive value creation services its in-house team provides to portfolio companies, which include investment readiness, exit readiness, IP strategy, senior executive placements, and financial-function support. Capital gains are realized separately through strategic partial or full exits from directly owned positions, while carried interest flows from successful exits within the managed fund portfolios.
How does EMV Capital source and manage its investments?
EMV sources investments primarily in the UK, with additional positions in the US and select international markets, concentrating on companies with defensible intellectual property. Post-investment, the firm takes board seats, works closely with management, and deploys an internal operational team supported by venture partners and a panel of expert service providers. This active management style focuses on guiding a select cohort of companies through growth milestones and preparing them for exit, with the firm maintaining close coordination with co-investors to align strategy and objectives over an extended holding period.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: